The investigators planned that clarithromycin treatment in preterm babies who are under 1250 grams birth weight.~The investigators aimed with this treatment, the bronchopulmonary dysplasia rate of preterm babies may decrease.
The purpose of this study is to determine of clarithromycin effect on developing of bronchopulmonary dysplasia in preterm babies.